{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:36:50Z","timestamp":1788565010671,"version":"build-2803163510"},"reference-count":48,"publisher":"Oceanside Publications Inc.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2021,11,1]]},"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> The management of chronic rhinosinusitis with nasal polyps (CRSwNP) is evolving, with an emphasis on treating the underlying type 2 inflammation.  <jats:bold>Objective:<\/jats:bold> The objective was to summarize the updated evidence-based medical and surgical treatment\n recommendations for CRSwNP, including the position of biologics in the treatment algorithm.  <jats:bold>Methods:<\/jats:bold> This review compared and contrasted the therapeutic recommendations presented by the European Position Paper on Rhinosinusitis and Nasal Polyps 2020 and the International\n Consensus Statement on Allergy and Rhinology: Rhinosinusitis 2021.  <jats:bold>Results:<\/jats:bold> The long-term use of intranasal corticosteroids and the short-term use of oral corticosteroids are strongly recommended, whereas corticosteroid-eluting implants are considered an option. Although\n the use of saline solution rinses is recommended, there is uncertainty as to whether irrigation is more effective than sprays. Oral aspirin (ASA) desensitization, followed by ASA \u2265 300 mg daily for patients with ASA-exacerbated respiratory disease may be considered. In general, the use\n of antifungal agents offers no benefit and potential harm. Although the use of oral antibiotics for an acute exacerbation is still debated, oral and topical antibiotics are discouraged for subacute or chronic use. Antileukotrienes are inferior to intranasal corticosteroids and are unlikely\n to provide added benefit when used concomitantly. It is unlikely that the benefit of oral antihistamines and decongestants outweigh the potential harm. Dupilumab is recommended for severe CRSwNP when consensus-determined criteria are met. Omalizumab may be an option with concomitant poorly\n controlled asthma. Mepolizumab and reslizumab may be used, particularly in patients with concomitant uncontrolled asthma. In allergic fungal rhinosinusitis, oral and topical antifungals, antileukotrienes, allergen immunotherapy, and omalizumab are therapeutic options. Although surgical intervention\n is recognized to be of benefit for CRSwNP, there are no evidence-based criteria to indicate when maximum medical treatment has failed.  <jats:bold>Conclusion:<\/jats:bold> An evidence-based CRSwNP treatment algorithm for when to recommend surgery and\/or initiate or discontinue biologics to maximize\n quality of life and cost-effectiveness is still lacking.<\/jats:p>","DOI":"10.2500\/aap.2021.42.210080","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T20:07:14Z","timestamp":1638821234000},"page":"450-460","source":"Crossref","is-referenced-by-count":32,"title":["Treatment options for chronic rhinosinusitis with nasal polyps"],"prefix":"10.2500","volume":"42","author":[{"given":"Dana V.","family":"Wallace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1355","reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhin20.401","article-title":"European position paper on rhinosinusitis and nasal polyps 2020 rhinology","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"B2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/alr.22741","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis 2021","volume":"11","author":"Orlandi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"B3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaci.2018.06.010","article-title":"NAVIGATE II: randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis","volume":"143","author":"Leopold","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/alr.22093","article-title":"Corticosteroid nasal irrigations are more effective than simple sprays in a randomized double-blinded placebo-controlled trial for chronic rhinosinusitis after sinus surgery","volume":"8","author":"Harvey","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"B5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.iac.2009.07.006","article-title":"Anti-inflammatory effects of macrolides: applications in chronic rhinosinusitis","volume":"29","author":"Harvey","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"B6","first-page":"1","article-title":"Comparison of the efficacy of nasal drop and nasal spray applications of fluticasone propionate in nasal polyps","volume":"18","author":"Demirel","year":"2008","journal-title":"Kulak Burun Bogaz Ihtis Derg"},{"key":"B7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4193\/Rhino14.196","article-title":"Post-operative budesonide irrigations for patients with polyposis: a blinded, randomized controlled trial","volume":"53","author":"Rawal","year":"2015","journal-title":"Rhinology"},{"key":"B8","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1002\/lary.22396","article-title":"Postoperative care for Samter's triad patients undergoing endoscopic sinus surgery: a double-blinded, randomized controlled trial","volume":"121","author":"Rotenberg","year":"2011","journal-title":"Laryngoscope"},{"key":"B9","first-page":"1639","article-title":"Clinical and immunological efficacy of aspirin desensitization in nasal polyp patients with aspirin-exacerbated respiratory disease","volume":"16","author":"Mortazavi","year":"2017","journal-title":"Iran J Pharm Res"},{"key":"B10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.clim.2015.05.012","article-title":"Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: a randomized double-blind placebo-controlled trial","volume":"160","author":"Esmaeilzadeh","year":"2015","journal-title":"Clin Immunol"},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.1002\/alr.22851","article-title":"Multidisciplinary consensus on a stepwise treatment algorithm for management of chronic rhinosinusitis with nasal polyps","author":"Han","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"B12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jaci.2020.10.043","article-title":"The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: a Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology","volume":"147","author":"Stevens","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1398-9995.2011.02693.x","article-title":"Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial","volume":"66","author":"Videler","year":"2011","journal-title":"Allergy"},{"key":"B14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/alr.22691","article-title":"Azithromycin in high-risk, refractory chronic rhinosinusitus after endoscopic sinus surgery and corticosteroid irrigations: a double-blind, randomized, placebo-controlled trial","volume":"11","author":"Maniakas","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"B15","first-page":"721","article-title":"Effects of preoperative clarithromycin administration in patients with nasal polyposis","volume":"63","author":"Peri\u0107","year":"2014","journal-title":"West Indian Med J"},{"key":"B16","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40264-017-0533-2","article-title":"Managing cardiovascular risk of macrolides: systematic review and meta-analysis","volume":"40","author":"Wong","year":"2017","journal-title":"Drug Saf"},{"key":"B17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/coa.12096","article-title":"Multimodality topical therapy for refractory chronic rhinosinusitis: our experience in thirteen patients with and twelve patients without nasal polyps","volume":"38","author":"Shikani","year":"2013","journal-title":"Clin Otolaryngol"},{"key":"B18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2500\/ajra.2016.30.4294","article-title":"Does oxymetazoline increase the efficacy of nasal steroids in treating nasal polyposis?","volume":"30","author":"Kirtsreesakul","year":"2016","journal-title":"Am J Rhinol Allergy"},{"key":"B19","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/alr.21172","article-title":"Distribution of topical agents to the paranasal sinuses: an evidence-based review with recommendations","volume":"3","author":"Thomas","year":"2013","journal-title":"Int Forum Allergy Rhinol"},{"key":"B20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaci.2020.11.013","article-title":"EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management","volume":"147","author":"Bachert","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"},{"key":"B22","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4193\/Rhino09.144","article-title":"A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis","volume":"48","author":"Pinto","year":"2010","journal-title":"Rhinology"},{"key":"B24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4193\/Rhin17.139","article-title":"Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study","volume":"56","author":"Bidder","year":"2018","journal-title":"Rhinology"},{"key":"B26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00405-019-05650-y","article-title":"Omalizumab versus intranasal steroids in the post-operative management of patients with allergic fungal rhinosinusitis","volume":"277","author":"Mostafa","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B27","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","article-title":"Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis","volume":"128","author":"Gevaert","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B28","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","article-title":"Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial","volume":"140","author":"Bachert","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B29","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial","author":"Han","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B30","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2006.05.031","article-title":"Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps","volume":"118","author":"Gevaert","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"B31","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/cea.13852","article-title":"Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): a randomized double-blind placebo-controlled trial","volume":"51","author":"Tversky","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"B32","first-page":"CD013513","article-title":"Biologics for chronic rhinosinusitis","volume":"3","author":"Chong","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"B33","article-title":"Dupixent prices, coupons, and patient assistance programs [internet]"},{"key":"B34","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1002\/lary.28648","article-title":"Cost utility analysis of dupilumab versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps","volume":"131","author":"Scangas","year":"2021","journal-title":"Laryngoscope"},{"key":"B35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.anai.2014.07.025","article-title":"Diagnosis and management of rhinosinusitis: a practice parameter update","volume":"113","author":"Peters","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B36","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/alr.21601","article-title":"When are we operating for chronic rhinosinusitis? A systematic review of maximal medical therapy protocols prior to endoscopic sinus surgery","volume":"5","author":"Dautremont","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"key":"B37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/alr.21769","article-title":"Defining appropriateness criteria for endoscopic sinus surgery during management of uncomplicated adult chronic rhinosinusitis: a RAND\/UCLA appropriateness study","volume":"6","author":"Rudmik","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"B38","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/lary.25108","article-title":"Using preoperative SNOT-22 score to inform patient decision for endoscopic sinus surgery","volume":"125","author":"Rudmik","year":"2015","journal-title":"Laryngoscope"},{"key":"B39","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.otohns.2007.02.004","article-title":"The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict?","volume":"137","author":"Hopkins","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B40","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/0194599818773065","article-title":"Systematic review and meta-analysis of SNOT-22 outcomes after surgery for chronic rhinosinusitis with nasal polyposis","volume":"159","author":"Le","year":"2018","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B41","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/all.12983","article-title":"Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre","volume":"72","author":"van der Veen","year":"2017","journal-title":"Allergy"},{"issue":"12","key":"B42","first-page":"CD006991","article-title":"Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps","author":"Rimmer","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B43","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/coa.13779","article-title":"British Rhinological Society Consensus Guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps","volume":"46","author":"Hopkins","year":"2021","journal-title":"Clin Otolaryngol"},{"key":"B44","article-title":"Dupixent [package Insert]","year":"2021"},{"key":"B45","article-title":"Xolair [package insert]","year":"2021"},{"key":"B46","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/alr.22397","article-title":"Extent of maxillary sinus surgery and its effect on instrument access, irrigation penetration, and disease clearance","volume":"9","author":"Govindaraju","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"B47","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/alr.22386","article-title":"Sinus irrigation penetration after balloon sinuplasty vs functional endoscopic sinus surgery in a cadaveric model","volume":"9","author":"Gantz","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"B48","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/alr.22371","article-title":"Effects of sphenoid surgery on nasal irrigation delivery","volume":"9","author":"Grayson","year":"2019","journal-title":"Int Forum Allergy Rhinol"}],"container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2021\/00000042\/00000006\/art00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T04:51:59Z","timestamp":1640235119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2021.42.210080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11,1]]}},"alternative-id":["1088-5412(20211101)42:6L.450;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2021.42.210080","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,1]]}}}